Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 117


Partial oral antibiotic therapy is non-inferior to intravenous therapy in non-critically ill patients with infective endocarditis : Review and meta-analysis.

Rezar R, Jirak P, Lichtenauer M, Jung C, Lauten A, Hoppe UC, Wernly B.

Wien Klin Wochenschr. 2020 Feb 10. doi: 10.1007/s00508-020-01614-z. [Epub ahead of print] Review.


Anti-CD3 Antibody Treatment Reduces Scar Formation in a Rat Model of Myocardial Infarction.

Wernly B, Paar V, Aigner A, Pilz PM, Podesser BK, Förster M, Jung C, Hofbauer JP, Tockner B, Wimmer M, Kraus T, Motloch LJ, Hackl M, Hoppe UC, Kiss A, Lichtenauer M.

Cells. 2020 Jan 25;9(2). pii: E295. doi: 10.3390/cells9020295.


Heart-Type Fatty Acid-Binding Protein (H-FABP) and its Role as a Biomarker in Heart Failure: What Do We Know So Far?

Rezar R, Jirak P, Gschwandtner M, Derler R, Felder TK, Haslinger M, Kopp K, Seelmaier C, Granitz C, Hoppe UC, Lichtenauer M.

J Clin Med. 2020 Jan 7;9(1). pii: E164. doi: 10.3390/jcm9010164. Review.


Impact of EMpagliflozin on cardiac function and biomarkers of heart failure in patients with acute MYocardial infarction-The EMMY trial.

Tripolt NJ, Kolesnik E, Pferschy PN, Verheyen N, Ablasser K, Sailer S, Alber H, Berger R, Kaulfersch C, Leitner K, Lichtenauer M, Mader A, Moertl D, Oulhaj A, Reiter C, Rieder T, Saely CH, Siller-Matula J, Weidinger F, Zechner PM, von Lewinski D, Sourij H; EMMY study group.

Am Heart J. 2020 Mar;221:39-47. doi: 10.1016/j.ahj.2019.12.004. Epub 2019 Dec 12.


Syndecan-1 Predicts Outcome in Patients with ST-Segment Elevation Infarction Independent from Infarct-related Myocardial Injury.

Wernly B, Fuernau G, Masyuk M, Muessig JM, Pfeiler S, Bruno RR, Desch S, Muench P, Lichtenauer M, Kelm M, Adams V, Thiele H, Eitel I, Jung C.

Sci Rep. 2019 Dec 4;9(1):18367. doi: 10.1038/s41598-019-54937-x.


Admission body temperature in critical ill patients as an independent risk predictor for overall outcome.

Erkens R, Wernly B, Masyuk M, Muessig J, Franz M, Schulze PC, Lichtenauer M, Kelm M, Jung C.

Med Princ Pract. 2019 Dec 2. doi: 10.1159/000505126. [Epub ahead of print]


MicroRNAs in Inflammatory Heart Diseases and Sepsis-Induced Cardiac Dysfunction: A Potential Scope for the Future?

Mirna M, Paar V, Rezar R, Topf A, Eber M, Hoppe UC, Lichtenauer M, Jung C.

Cells. 2019 Oct 30;8(11). pii: E1352. doi: 10.3390/cells8111352. Review.


Pathophysiology of Calcium Mediated Ventricular Arrhythmias and Novel Therapeutic Options with Focus on Gene Therapy.

Paar V, Jirak P, Larbig R, Zagidullin NS, Brandt MC, Lichtenauer M, Hoppe UC, Motloch LJ.

Int J Mol Sci. 2019 Oct 24;20(21). pii: E5304. doi: 10.3390/ijms20215304. Review.


Response to Letter to the Editor Analysis of Novel Cardiovascular Biomarkers in Patients With Pulmonary Hypertension (PH).

Mirna M, Lichtenauer M.

Heart Lung Circ. 2019 Nov;28(11):e149-e150. doi: 10.1016/j.hlc.2019.05.169. No abstract available.


Systematic Review and Meta-Analysis of Interventional Emergency Treatment of Decompensated Severe Aortic Stenosis.

Wernly B, Jirak P, Lichtenauer M, Veulemans V, Zeus T, Piayda K, Hoppe UC, Lauten A, Frerker C, Jung C.

J Invasive Cardiol. 2020 Jan;32(1):30-36. Epub 2019 Oct 15.


Easy prognostic assessment of concomitant organ failure in critically ill patients undergoing mechanical ventilation.

Wernly B, Frutos-Vivar F, Peñuelas O, Raymondos K, Muriel A, Du B, Thille AW, Ríos F, González M, Del-Sorbo L, Del Carmen Marín M, Pinheiro BV, Soares MA, Nin N, Maggiore SM, Bersten A, Kelm M, Amin P, Cakar N, Lichtenauer M, Suh GY, Abroug F, Jibaja M, Matamis D, Zeggwagh AA, Sutherasan Y, Anzueto A, Esteban A, Jung C.

Eur J Intern Med. 2019 Dec;70:18-23. doi: 10.1016/j.ejim.2019.09.002. Epub 2019 Oct 9.


Research update for articles published in EJCI in 2017.

Arellano-Orden E, Bacopoulou F, Baicus C, Bonfrate L, Broadbent J, Buechler C, Carbone F, Charmandari E, Davis GR, Dullaart RPF, Efthymiou V, Goeser F, Goswami N, Jong GP, Lichtenauer M, Liou YS, Lutz P, Maeng M, Mert GÖ, Mert KU, Montecucco F, Ndrepepa G, Olesen KKW, Oliveira P, Perton FG, Portincasa P, Rodriguez-Panadero F, Schernthaner C, Schutte R.

Eur J Clin Invest. 2019 Oct;49(10):e13163. doi: 10.1111/eci.13163. Epub 2019 Sep 16. No abstract available.


miR-19a-3p containing exosomes improve function of ischemic myocardium upon shock wave therapy.

Gollmann-Tepeköylü C, Pölzl L, Graber M, Hirsch J, Nägele F, Lobenwein D, Hess MW, Blumer MJ, Kirchmair E, Zipperle J, Hromada C, Mühleder S, Hackl H, Hermann M, Khamisi HA, Förster M, Lichtenauer M, Mittermayr R, Paulus P, Fritsch H, Bonaros N, Kirchmair R, Sluijter JPG, Davidson S, Grimm M, Holfeld J.

Cardiovasc Res. 2019 Aug 13. pii: cvz209. doi: 10.1093/cvr/cvz209. [Epub ahead of print]


Analysis of Novel Cardiovascular Biomarkers in Patients With Pulmonary Hypertension (PH).

Mirna M, Rohm I, Jirak P, Wernly B, Bäz L, Paar V, Kretzschmar D, Hoppe UC, Schulze PC, Lichtenauer M, Jung C, Franz M.

Heart Lung Circ. 2019 Apr 1. pii: S1443-9506(19)30293-8. doi: 10.1016/j.hlc.2019.03.004. [Epub ahead of print]


Transcatheter aortic valve implantation in a patient with suspected hereditary von Willebrand disease and severe gastrointestinal bleeding - a case report.

Mirna M, Lichtenauer M, Theurl T, Ausserwinkler M, Topf A, Westphal T, Gampenrieder SP, Pretsch I, Greil R, Hoppe UC.

Scott Med J. 2019 Nov;64(4):142-147. doi: 10.1177/0036933019862155. Epub 2019 Jul 19.


Correction to: Antithrombotic therapy in atrial fibrillation: stop triple therapy and start optimizing dual therapy?

Wernly B, Lichtenauer M, Erlinge D, Jung C.

Clin Res Cardiol. 2020 Jan;109(1):131. doi: 10.1007/s00392-019-01510-1.


Old Dog, New Tricks - CA125 for Risk Stratification in TAVI Patients.

Wernly B, Lichtenauer M.

Rev Esp Cardiol (Engl Ed). 2019 Nov;72(11):892-895. doi: 10.1016/j.rec.2019.04.008. Epub 2019 Jun 4. English, Spanish. No abstract available.


Potential mechanisms of endothelialisation in individuals implanted with a leadless pacemaker systems: An experimental in vitro study.

Edlinger C, Paar V, Tuscher T, Jirak P, Motloch LJ, Kammler J, Blessberger H, Kraus J, Hoppe UC, Steinwender C, Kypta A, Lichtenauer M.

J Electrocardiol. 2019 Jul - Aug;55:72-77. doi: 10.1016/j.jelectrocard.2019.04.012. Epub 2019 Apr 23.


Antithrombotic therapy in atrial fibrillation: stop triple therapy and start optimizing dual therapy?

Wernly B, Lichtenauer M, Erlinge D, Jung C.

Clin Res Cardiol. 2020 Jan;109(1):128-130. doi: 10.1007/s00392-019-01496-w. Epub 2019 May 29. No abstract available. Erratum in: Clin Res Cardiol. 2019 Jul 5;:.


Autoimmune myocarditis is not associated with left ventricular systolic dysfunction.

Mirna M, Paar V, Kraus T, Sotlar K, Wernly B, Pistulli R, Hoppe UC, Lichtenauer M.

Eur J Clin Invest. 2019 Aug;49(8):e13132. doi: 10.1111/eci.13132. Epub 2019 Jun 14.

Supplemental Content

Loading ...
Support Center